Tau pathology induces intraneuronal cholesterol accumulation

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 9, 2014, Pages 846-854

  Glöckner, Frauke ^a   Ohm, Thomas G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cholesterol; Filipin; Neurofibrillary tangle; Tau; Tauopathy

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; FILIPIN; TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CHOLESTEROL HOMEOSTASIS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HOMEOSTASIS; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MOUSE; MOUSE MODEL; NERVE CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TAUOPATHY; ANIMAL; BRAIN; CELL NUCLEUS INCLUSION BODY; CONFOCAL MICROSCOPY; DEFICIENCY; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SILVER STAINING; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT; ULTRASTRUCTURE;

ANIMALS; APOLIPOPROTEINS E; BRAIN; CHOLESTEROL; DISEASE MODELS, ANIMAL; HUMANS; INTRANUCLEAR INCLUSION BODIES; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NEURONS; SILVER STAINING; TAU PROTEINS; TAUOPATHIES; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84906936733     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000103     Document Type: Article

References (48)

1. Weingarten MD, Lockwood AH, Hwo SY, et al. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 1975;72: 1858-62
2. Trinczek B, Ebneth A, Mandelkow EM, et al. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J Cell Sci 1999;112:2355-67 (Pubitemid 29381026)
3. He HJ, Wang XS, Pan R, et al. The proline-rich domain of tau plays a role in interactions with actin. BMC Cell Biol 2009;10:81
4. Gallo G. Tau is actin up in Alzheimer's disease. Nat Cell Biol 2007;9: 133-34 (Pubitemid 46420853)
5. Pooler AM, Usardi A, Evans CJ, et al. Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol Aging 2012;33:431-38
6. Lee G. Tau and src family tyrosine kinases. Biochim Biophys Acta 2005; 1739:323-30 (Pubitemid 40018548)
7. Grundke Iqbal I, Iqbal K, Tung YC, et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-17
8. Spillantini MG, Tolnay M, Love S, et al. Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia. Acta Neuropathol (Berl) 1999;97:585-94 (Pubitemid 29231676)
9. Treiber-Held S, Distl R, Albert F, et al. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease. J Pathol 2003;200:95-103 (Pubitemid 36592642)
10. Distl R, Treiber-Held S, Albert F, et al. Cholesterol storage and taupathology in Niemann-Pick type C disease brain. J Pathol 2003;200: 104-11 (Pubitemid 36592643)
11. Distl R, Meske V, Ohm TG. Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol 2001; 101:547-54 (Pubitemid 32684752)
12. Gellermann GP, Appel TR, Davies P, et al. Paired helical filaments contain small amounts of cholesterol, phosphatidylcholine and sphingolipids. Biol Chem 2006;387:1267-74 (Pubitemid 44402074)
13. Cerami C, Scarpini E, Cappa SF, et al. Frontotemporal lobar degeneration: Current knowledge and future challenges. J Neurol 2012;259: 2278-86
14. Verpillat P, Camuzat A, Hannequin D, et al. Apolipoprotein E gene in frontotemporal dementia: An association study and meta-analysis. Eur J Hum Genet 2002;10:399-405
15. Ohm TG, Scharnagl H, März W, et al. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's diseaseYrelated lesions. Acta Neuropathol (Berl) 1999;98:273-80
16. Götz J, Chen F, Barmettler R, et al. Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2001;276:529-34
17. Götz J, Chen F, Van Dorpe J, et al. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001; 293:1491-95
18. Glöckner F, Meske V, Lütjohann D, et al. Dietary cholesterol and its effect on tau protein: A study in apolipoprotein EYdeficient and P301L human tau mice. J Neuropathol Exp Neurol 2011;70:292-301
19. Paxinos G, Franklin KJ. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. San Diego, CA: Academic Press, 1997
20. Mercken M, Vandermeeren M, Lubke U, et al. Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992;84:265-72
21. Ackermann H. BiAS: A Program Package for Biometrical Analysis of Samples. Version 8.4. Hochheim Darmstadt, Germany: Epsilon-Verlag, 2008
22. Saito Y, Suzuki K, Nanba E, et al. Niemann-Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon4 homozygosity. Ann Neurol 2002;52:351-55 (Pubitemid 35001503)
23. Fu R, Yanjanin NM, Elrick MJ, et al. Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1. Am J Med Genet A 2012;158A:2775-80
24. Zheng Fischhofer Q, Biernat J, Mandelkow EM, et al. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filamentYlike conformation. Eur J Biochem 1998;252:2542-52
25. Jansen PJ, Lütjohann D, Thelen KM, et al. Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels. J Alzheimers Dis 2009;18:319-29
26. Levi O, Lütjohann D, Devir A, et al. Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation. J Neurochem 2005;95:987-97
27. Eckert GP, Kirsch C, Mueller WE. Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice. NeuroReport 2001;12:883-87 (Pubitemid 32281439)
28. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001;294:1354-57 (Pubitemid 33063104)
29. Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 2008;9:125-38 (Pubitemid 351158918)
30. Johansson M, Rocha N, Zwart W, et al. Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor {beta}lll spectrin. J Cell Biol 2007;176:459-71
31. Pacheco CD, Elrick MJ, Lieberman AP. Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis. Hum Mol Genet 2009;18:956-65
32. Vershinin M, Carter BC, Razafsky DS, et al. Multiple-motor based transport and its regulation by Tau. Proc Natl Acad Sci USA 2007;104: 87-92 (Pubitemid 46067989)
33. Pooler AM, Hanger DP. Functional implications of the association of tau with the plasma membrane. Biochem Soc Trans 2010;38:1012-15
34. Yamauchi Y, Reid PC, Sperry JB, et al. Plasma membrane rafts complete cholesterol synthesis by participating in retrograde movement of precursor sterols. J Biol Chem 2007;282:34994-5004 (Pubitemid 350232452)
35. Whitehead SN, Gangaraju S, Aylsworth A, et al. Membrane raft disruption results in neuritic retraction prior to neuronal death in cortical neurons. Biosci Trends 2012;6:183-91
36. Sawamura N, Gong JS, Chang TY, et al. Promotion of tau phosphorylation by MAP kinase Erk1/2 is accompanied by reduced cholesterol level in detergent-insoluble membrane fraction in Niemann-Pick C1Ydeficient cells. J Neurochem 2003;84:1086-96 (Pubitemid 36330661)
37. Mandelkow EM, Mandelkow E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2012;2:a006247
38. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-30
39. Schwiegelshohn B, Presley JF, Gorecki M, et al. Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem 1995;270:1761-69
40. Igbavboa U, Avdulov NA, Chochina SV, et al. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J Neurochem 1997;69:1661-67 (Pubitemid 27406967)
41. Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, et al. Apolipoprotein E and beta-amyloid (1Y42) regulation of glycogen synthase kinase-3beta. J Neurochem 2003;87:1152-64 (Pubitemid 37492856)
42. Wang X, Luebbe P, Gruenstein E, et al. Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways. J Neurosci Res 1998;51:658-65 (Pubitemid 28115067)
43. Cataldo AM, Barnett JL, Berman SA, et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995;14: 671-80
44. Nixon RA, Yang DS. Autophagy failure in Alzheimer's diseaseVlocating the primary defect. Neurobiol Dis 2011;43:38-45
45. Meske V, Erz J, Priesnitz T, et al. The autophagic defect in Niemann-Pick disease type C neurons differs from somatic cells and reduces neuronal viability. Neurobiol Dis 2014;64C:88-97
46. Ordonez MP, Roberts EA, Kidwell CU, et al. Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1. Hum Mol Genet 2012;21:2651-62
47. Pacheco CD, Elrick MJ, Lieberman AP. Tau normal function influences Niemann-Pick type C disease pathogenesis in mice and modulates autophagy in NPC1-deficient cells. Autophagy 2009;5:548-50
48. Ittner LM, Fath T, Ke YD, et al. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc Natl Acad Sci USA 2008;105:15997-6002